The advent of the Omicron variant
Huang, C., et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020. 395(10223): p. 497-506.
World Health Organisation. Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern. 2021 [cited 2021 22/12/2021]; Available from: https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern.
Domingo, E., et al., Mutation Rates, Mutation Frequencies, and Proofreading-Repair Activities in RNA Virus Genetics. Viruses, 2021. 13(9).
World Health Organisation. Update on Omicron. 2021 22/12/2021]; Available from: https://www.who.int/news/item/28-11-2021-update-on-omicron.
Dyer, O., Covid-19: South Africa's surge in cases deepens alarm over omicron variant. BMJ, 2021. 375: p. n3013.
WHO Collaborating Centre for Infectious Disease Modelling, Report 49 - Growth, population distribution and immune escape of Omicron in England, J.I. MRC Centre for Global Infectious Disease Analysis, Imperial College London., Editor. 2021.
Head, E., van Esland, S. https://www.imperial.ac.uk/news/232698/modelling-suggests-rapid-spread-omicron-england/. Imperial College London 2021; Available from: https://www.imperial.ac.uk/news/232698/modelling-suggests-rapid-spread-omicron-england/.
Cele, S., et al., SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection. medRxiv, 2021.
Bo, M., Ferreira, I., et al., SARS-CoV-2 Omicron spike mediated immune escape, infectivity and cell-cell fusion. 2021: BIORXIV.
Mahase, E., Covid-19: Pfizer's paxlovid is 89% effective in patients at risk of serious illness, company reports. BMJ, 2021. 375: p. n2713.
Mahase, E., Covid-19: UK approves monoclonal antibody sotrovimab for over 12s at high risk. BMJ, 2021. 375: p. n2990.
McIntyre, P.B., et al., COVID-19 vaccine strategies must focus on severe disease and global equity. Lancet, 2021.
Irwin, A., What it will take to vaccinate the world against COVID-19, in Nature. 2021.
Erman, M., Farge, E., https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-allow-generic-versions-its-covid-19-pill-95-countries-2021-11-16/, in Reuters. 2021.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2021 Array